Professor of Population Health Sciences Associate Dean, Master's Programs
Dr. Schackman conducts research relating to economic evaluations of the comparative effectiveness of health interventions conducted alongside clinical trials and cohort studies, cost-effectiveness and comparative effectiveness simulation modeling, and implementation science studies — particularly relating to treatment of infectious diseases and substance use.
Dr. Schackman has a distinguished record of continuous funding from NIH/NIDA and is currently beginning his ninth year as PI of the Center for Health Economics of Treatment Interventions for Substance Use Disorder, HCV, and HIV (CHERISH), a NIDA-supported multi-institutional P30 national center of excellence. He also leads NIDA-funded R01 and U01 research projects and was recently awarded another modeling and economic resource center grant from NIDA as part of the NIH HEAL (Helping to End Addiction Long-Term) initiative. Dr. Schackman has collaborated with NIH-supported clinical trials and simulation modeling teams to undertake policy-relevant studies examining the economic implications of integrating HIV, HCV, and substance use treatment and the cost-effectiveness of alternative treatments for opioid use disorder in different clinical settings. He has also made important scientific advances in measuring quality of life related to HIV, HCV, and opioid use disorder.
Current and recent projects include assessing the feasibility and acceptability of HIV, HCV, and opioid use disorder services in syringe service programs nationally; optimizing naloxone distribution for prevention of fatal opioid overdoses in New York City, Massachusetts, and Rhode Island; economic evaluation of the HEALing Communities Study of community interventions to reduce incidence of fatal overdoses in four states; and simulation modeling to optimize allocation of public health program resources to achieve Ending the HIV Epidemic targets in Miami.
Biography
Dr. Schackman completed his MBA at the Harvard Business School and received his PhD in Health Policy from Harvard in 2001, after which he joined Weill Cornell Medicine as an assistant professor. In 2007 he was promoted to associate professor, in 2011 he received tenure, and in 2013 he was appointed as full professor at WCM and WCGS. Since 2015 he has been the Saul P. Steinberg Distinguished Professor of Healthcare Policy & Research. He is also Executive Vice Chair of the WCM Department of Population Health Sciences and holds secondary appointments in the WCM Departments of Medicine and Psychiatry.
Distinctions:
Named honoree, Lee B. Lusted SubAward for Health Services Outcomes & Policy Research, Society for Medical Decision Making, 2021
Elected Member, College on Problems of Drug Dependence, 2016
“Research in Action Award,” Treatment Action Group
